STE as reported
STERIS plc reported $5.94B of revenue over the trailing twelve months, +8.7% on the year before. 11 reported series are charted on this page, each one as filed.
$5.94B
Revenue, trailing twelve months · to Q4 2026 · +8.7% against the twelve months before
- Net Income
- $782M
Net Income · +27% year on year · trailing twelve months to Q4 2026
- Free Cash Flow
- $972M
Free Cash Flow · +25% year on year · trailing twelve months to Q4 2026
- Op Margin
- 19%
Op Margin · trailing twelve months to Q4 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $5.94B | +8.7% | Q4 2026 |
| Net Income | $782M | +27% | Q4 2026 |
| EPS | $7.93 | +28% | Q4 2026 |
| Gross Margin | 44% | n/a | Q4 2026 |
| Op Margin | 19% | n/a | Q4 2026 |
| Net Margin | 13% | n/a | Q4 2026 |
| ROE | 10.0% | n/a | Q4 2026 |
| ROA | 6.7% | n/a | Q4 2026 |
| ROIC | 9.2% | n/a | Q4 2026 |
| Free Cash Flow | $972M | +25% | Q4 2026 |
| P/E | 29.9 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
STERIS plc (STE) - Revenue & ProfitRevenue & ProfitSTERIS plc (STE)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Devices
Ranks #13 of 35 by Smart Score